Tattoo Cream
NDC Package 85942-001-01
Package Information
Tattoo (tattoo cream) cream is as directed by the physician. This formulation utilizes a cream delivery system. Marketed by Perfso (hk) Co., Limited, this product is identified by NDC 85942-001 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 2719425 - EPINEPHrine 1 % / lidocaine 5 % Topical Cream
- RxCUI: 2719425 - epinephrine 10 MG/ML / lidocaine 50 MG/ML Topical Cream
- RxCUI: 2719425 - epinephrine 1 % / lidocaine 5 % Topical Cream
Clinical Specifications
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Antiarrhythmic - [EPC] (Established Pharmacologic Class)
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- Local Anesthesia - [PE] (Physiologic Effect)
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 85942 - Perfso (hk) Co., Limited
- 85942-001 - Tattoo
- 85942-001-01 - 10 g in 1 BOX
- 85942-001 - Tattoo
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85942-001-01 identifies a specific commercial package of 10 g in 1 box of Tattoo, a human over the counter drug labeled by Perfso (hk) Co., Limited. This cream is formulated for cutaneous use and contains epinephrine; lidocaine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Perfso (hk) Co., Limited on July 09, 2025. The current certification is valid through December 31, 2026.
How is this Perfso (hk) Co., Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85942000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.